New approvals in the neoadjuvant and adjuvant settings of HER2positive early breast cancer are increasing the complexity of selecting optimal treatment This patient case challenges you to navigate the treatment options based on initial disease burden treatment tolerability HER2 reassessment response to neoadjuvant treatment and currently available trial evidence
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
Address:
- 12001 Sunrise Valley Drive
Pricing
98% of listed courses are free
294 of a sample of 300 are free · 531 courses listed here.
Collected from the provider’s public pages · source
Specialties served/covered
- Addiction Medicine
- Advanced Heart Failure & Transplant Cardiology
- Allergy & Clinical Immunology
- Anatomic & Clinical Pathology
- Cardiovascular Disease
- Clinical Informatics
- Clinician Wellness & Burnout
- Communication & Shared Decision-Making
- Critical Care Medicine
- Dermatology
- Diagnostic Radiology
- Emergency Medicine
- Endocrinology, Diabetes & Metabolism
- Evidence-Based Medicine & Research
- Family Medicine
- Gastroenterology
- Gastrointestinal Surgery
- General & Adult Psychiatry
- General Internal Medicine
- General Pediatrics
- Geriatric Medicine
- Geriatric Psychiatry
- Head & Neck Surgery
- Health Equity & Inclusion
- Hematology
- Infectious Disease
- Laryngology
- Medical Genetics & Genomics
- Medical Leadership & Administration
- Medical Oncology
- Metabolic & Bariatric Surgery
- Mood & Anxiety Disorders
- Neonatal-Perinatal Medicine
- Nephrology
- Neurology
- Neuromuscular Medicine
- Neuroradiology
- Obstetrics & Gynecology
- Otology & Neurotology
- Pain Medicine
- Patient Education & Health Literacy
- Patient Safety & Quality Improvement
- Pediatric Hematology-Oncology
- Pediatric Infectious Diseases
- Pediatric Otolaryngology
- Psychopharmacology
- Psychotic Disorders
- Pulmonary Disease
- Rheumatology
- Sleep Medicine
- Surgical Oncology
- Thoracic Surgery
- Transplant Hepatology
- Cardio-Vascular
- Cross-Specialty
- Emergency & Critical Care
- ENT & Head Neck
- GI & Liver
- Infectious Disease
- Internal Medicine
- Medical Subspecialties
- Neurology
- Ob/Gyn
- Oncology & Hematology
- Pain & Palliative
- Pathology & Lab
- Pediatrics
- Primary care
- Psychiatry
- Radiology
- No reviews yet. Be the first to share yours.
Pricing
Free
Reported to ACCME by the provider
- On-demand / recorded video
- includes Case study / clinical scenario
- Credit · Up to 0.5 credits
- MOC · Up to 0.5 points
- Commercial Support
-
ReleasedOct 6, 2026
-
Last day to claim creditApr 6, 2027 6 months left
-
Answers in CME Inc. (AiCME) Bridging Clinic and OR: A Dialogue on the Emerging Role of Neoadjuvant HER2-Directed ADCs in HER2+ Breast Cancer
-
National Comprehensive Cancer Network Case Challenge: Optimizing Adjuvant Therapy for a 39-Year-Old Premenopausal Woman With High-Risk HR-Positive/HER2-Negative Early Breast Cancer
-
PRIME Education, Inc. (PRIME®) Personalizing Adjuvant Therapy in HR+/HER2- Early-Stage Breast Cancer Based on Latest Evidence and Patient-Specific Factors
-
Clinical Care Options, LLC (dba Decera Clinical Education) Personalizing Treatment for Early-Stage Breast Cancer: Where We Are and Where We Are Headed
-
Clinical Care Options, LLC (dba Decera Clinical Education) Evolving Treatment Landscape for HER2-Positive Early Breast Cancer
-
Clinical Care Options, LLC (dba Decera Clinical Education) Integrating HER2-Directed ADCs Across Early and Metastatic Breast Cancer: Practical Strategies for Testing, Sequencing, and Patient-Centered Care
